Sign inGet started

Horvath Susan

Insider CIK 1322846 · SNBP V.P. of Finance & CFO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PBLA Panbela Therapeutics, Inc. A Award deriv2024-10-012024-10-0325,480— $025,480SEC↗
PBLA Panbela Therapeutics, Inc. A Award deriv2023-03-272023-03-2934,369— $034,369SEC↗
PBLA Panbela Therapeutics, Inc. P Buy deriv2023-01-302023-02-018,888— $08,888SEC↗
PBLA Panbela Therapeutics, Inc. P Buy2023-01-302023-02-014,444— $017,880SEC↗
PBLA Panbela Therapeutics, Inc. A Award deriv2021-09-132021-09-1512,135— $012,135SEC↗
PBLA Panbela Therapeutics, Inc. A Award deriv2021-03-302021-04-0140,000— $040,000SEC↗
SNBP Sun BioPharma, Inc. P Buy deriv2020-09-012020-09-012,424— $02,424SEC↗
SNBP Sun BioPharma, Inc. P Buy2020-09-012020-09-012,424— $013,436SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2020-06-242020-06-2632,000— $032,000SEC↗
SNBP Sun BioPharma, Inc. P Buy deriv2020-06-052020-06-092,500— $02,500SEC↗
SNBP Sun BioPharma, Inc. P Buy2020-06-052020-06-092,500— $011,012SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-09-242019-09-2625,000— $025,000SEC↗
SNBP Sun BioPharma, Inc. P Buy deriv2019-08-302019-09-041,428— $01,428SEC↗
SNBP Sun BioPharma, Inc. P Buy2019-08-302019-09-041,428— $08,512SEC↗
SNBP Sun BioPharma, Inc. C Conversion deriv2019-06-302019-07-0223,625— $00SEC↗
SNBP Sun BioPharma, Inc. C Conversion2019-06-302019-07-027,084— $07,084SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-05-212019-05-2348,300— $048,300SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-05-212019-05-239,500— $09,500SEC↗
SNBP Sun BioPharma, Inc. P Buy deriv2018-12-312019-01-0323,625— $00SEC↗
SNBP Sun BioPharma, Inc. P Buy deriv2018-12-312019-01-0313,500— $013,500SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2018-04-172018-04-1940,000— $040,000SEC↗